Indian Pharmaceutical Company
Pharmaceutical Company

Investing in an Indian Pharmaceutical Company – A Profitable Deal

438 Views

India is doing extremely well in the pharmaceutical industry for over a few decades. The basic reasons are the availability of affordable labor and raw materials in abundance. The top pharma companies in India are discovering new molecules and bringing new medicines on board to curb various diseases and pathogens making human and animals’ life better than ever.

Medicine manufacturers in India have become a blessing for the business holders and shareholders due to the world’s dependency on India for APIs and other types of medicines. India supplies over 50% of the vaccines of the world. The UK receives 40% of generic medicine and the UK obtains 2% of all medicines from this country. It leaves no doubt that the industry of pharmaceuticals is growing by leaps and bounds and many business holders are eyeing it to make a massive profit.

A statistical view of the Indian pharma industry:

India is a country to deliver the 2nd largest share of biotech and pharma labors to the entire world. 2019 has greeted Rs. 1.4 lakh crore of domestic pharma market turnovers. In 2018, it was Rs 1.29 which indicates there was a 9.8% increase in a single year. Indian pharmaceutical export companies have employed a huge number of employees in various departments to perfectly cater to the needs of manufacturing and export medicines to all other parts of the world.

The sales of pharma products reached 9% (Rs 10,342 crore) in this year’s May. Moving Annual Total based calculation depicts that in December 2019, the pharma industry was at a growth of 9.8% with a price hike of 5.3%, and a volume hike of 2% y-o-y.

New Indian pharmaceutical company is emerging:

The colossal growth of the pharma industry has urged many business holders to invest in it and hence, many new Indian pharmaceutical companies are starting their journey in the league. Over 200 countries throughout the world import pharma products from India paving the golden way for any medicine exporter from India to increase their activities.

India is considered the most substantial provider of generic medicines globally. It consistently maintains its supremacy in this field making itself a hope for the investors. Again, owing to the growing number of pathogens and various diseases, the top pharma companies in India are intensifying their research and development, and manufacturing medicines on a large scale. Some of the best medicine manufacturers in India, for instance, JoinHub Pharma and others, are commercializing innovative therapies to curb the patients’ suffering.

Moreover, the price is kept affordable so that people of all economical strata can purchase medicines and other pharma products. In fact, the companies are looking after the improvement of the Indian pharmaceutical exports to reach every corner of the world where medicines and injectables are needed.

Therefore, it leaves no doubt that medicine manufacturers in India are business people’s dream. By this year’s September, the country has exported a record worth of US$ 11.80 billion of pharma products. As per the statistical prediction, the medical devices industry is constantly growing by at least 15.2% annually and can come to US$ 25 billion by 2025.

Unquestionable development of pharmaceutical medicine suppliers:

The top pharma companies in India that manufacture, pack, and supply medicines are committed completely to acquire the right quality at a rapid speed. Plus, they adopt cost-effective procedures at each stage of development. These firms are experts in industrialization and make sure that the end products are okay for manufacturing and commercialization at a large scale. The stakeholders can save a lot of money and time by investing in these firms.

Infact, the Government of India (Department of Pharmaceuticals) has launched Pharma Vision 2020 with the conceptualization of making India a comprehensive drug discovery hub. Under Union Budget 2020-21, the Ministry of Health and Family Welfare has allocated Rs. 65,012 crore indicating massive development of this industry.

Again, the project managers of the high profile Indian pharmaceutical company are deeply concentrating on the needs of customers. The focus is also on the timely delivery of the drugs including tablets, injections, capsules, ointment, oral liquid, suspensions, external preparations cream, nasal drops, eye, and ear drops, etc.

Furthermore, the coronavirus has made it immensely necessary to have multivitamins and minerals supplement on a regular basis. The top-notch medicine manufacturers in India are keen on manufacturing multivitamins and minerals along with hand sanitizers and protective masks to stop the deadly virus from entering the body and attack the immune system.

 

Conclusion:

The pharma industry in India will touch $65 billion by the year 2024 as per prediction. Any accredited and certified Indian pharmaceutical company is actively involved in contract manufacturing drug intermediates and active pharma ingredients and is making an unparalleled track record in the international market. The current focus is more on pharma innovation backed by ground-breaking science. All these aspects result in a positive opportunity for the investors to invest in the top medicine manufacturers in India making the country become number 1 in the pharmaceutical industry.

Simply give us a call on +91 99793 82527 or drop us a mail at [email protected]

Leave a comment

CALL ME BACK